Printer Friendly

Research and Markets: Vaccine Antigen Delivery Technologies - Molecular Systems to Open New Markets.

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/c0c134/vaccine_antigen_de) has announced the addition of the "Vaccine Antigen Delivery Technologies - Molecular Systems to Open New Markets" report to their offering.

As a result of the increasing switch from live-attenuated and killed whole-cell vaccines to subunit antigens, there is a need for novel antigen delivery technologies to improve vaccine efficacy and safety. This report assesses key strategies, technologies and products for vaccine antigen delivery. It provides an overview of opportunities and challenges for the sector and a future outlook.

* In-depth analysis of key vaccine antigen delivery technologies

* Thorough assessment of the potential for selected vaccine antigen delivery technologies

* Review of industry and academic stakeholder opinions involved in the vaccine antigen delivery sector

* In-depth discussion of key opportunities and risks for novel vaccine antigen delivery technologies

There is a significant need for novel vaccine antigen delivery technologies following the increasing switch from live-attenuated and killed whole-cell vaccines to subunit antigens. Key drivers for the sector are the need for increased immunogenicity and safety as well as for vaccine formulations combining delivery systems and adjuvant.

Virus-like particles and virosomes, both benefiting from the successful track record of already marketed vaccines, have the best potential in the short- to mid term. ISCOM-based technologies could be valuable for therapeutic vaccines, while liposomes and micro-/nanoparticles will not play a major role for vaccine delivery in the foreseeable future.

Antigen stability, safety and immunogenicity are the key hurdles for novel antigen delivery technologies. In times of restricted healthcare budgets, pricing and manufacturing costs need to be kept to a minimum. The limited understanding of the detailed molecular mechanisms for many technologies poses a further challenge.

* Review profiles of key vaccine antigen delivery technologies both marketed and in clinical development and assess their future potential

* Gain insight into the current state of vaccine antigen delivery technologies and their future opportunities and challenges

* Benefit from opinions of key industry and academic stakeholders in the vaccine antigen delivery field

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Antigen Types For Human Vaccines

Chapter 3 Rationale For The Development Of Novel Antigen Delivery Systems

Chapter 4 Challenges For The Development Of Novel Antigen Delivery Vehicles

Chapter 5 Bacterial/Viral Vectors

Chapter 6 Liposomes

Chapter 7 Virosomes

Chapter 8 Virus-Like Particles

Chapter 9 Iscom/Iscomatrix

Chapter 10 Microparticles/Nanoparticles

For more information visit http://www.researchandmarkets.com/research/c0c134/vaccine_antigen_de

Source: Datamonitor
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 12, 2009
Words:407
Previous Article:Research and Markets: Software/System Modeling and Test Tools - Volume 5: End-User Data on Software/System Modeling.
Next Article:Norman C.T. Liu Promoted to President and CEO of GECAS; Henry A. Hubschman to Become Chairman of GECAS.
Topics:

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters